Navigation Links
Our Own Cells May Be Answer to Treating Chronic Back Pain

Our own cells may be the answer to eliminating chronic neck or back pain and repairing damaged discs in our spine.

So comments interventional spine and pain management specialist Jason Arora, DO, who says using a patient’s blood plasma, which is rich in antibodies, enzymes and proteins, or stem cells harvested from a patient’s bone marrow are proving effective therapies for eliminating discogenic pain, namely pain caused by deteriorating or injured spinal discs, and restoring disc function.

Platelet-rich plasma injections (PRP) and stem-cell treatments are ushering in a “new dawn” in orthopedic care, says Dr. Arora, a physician and member of the team, at the Atlantic Spine Center, based in the New Jersey-New York area.

“These biological, restorative approaches may be the ‘Holy Grail’ for which we have been searching to bring relief to our patients who fail conservative treatments like exercise, physical therapy and medications, but who are unable, or do not want, to undergo surgery,” Dr. Arora states.

Many researchers concur.
A scientific study review published in March 2018 in the Journal of Spine Surgery indicates clinical evidence of the safety, effectiveness and feasibility of PRP therapy for discogenic back and neck pain. In fact, authors of the review call PRP a “new and exciting” prospect for treating degenerative disc disease and other musculoskeletal disorders.

Another 2018 report – this one published in July in the Biomedical Journal of Scientific and Technical Research -- concludes that bone marrow concentrate, which is frequently taken from the patient’s pelvis or hip bone and contains stem cells useful in healing, is an “attractive modality to treat lower back pain due to its low rate of adverse effects, compared to surgery.”

Lower back pain is reportedly the second leading cause of disability in the United States, according to the Centers for Disease Control and Prevention, and much of that pain can be attributed to degenerative disc disease, Dr. Arora says.

Imaging studies have shown presence of disc disease in about 40 percent of persons under age 30 and 90 percent of those over 50. That’s because incidence of this disease increases with age.

“Spinal discs are complicated structures that sit between the vertebrae and act as shock absorbers,” Dr. Arora explains. “They contain a gelatin interior and an exterior of collagen tissue known as the annulus fibrosus. As we age, discs can lose water content, become brittle and deteriorate.”

Of course, not all deteriorated spinal discs cause discogenic pain, but degenerative disc disease can initiate a cascade of physical events that ultimately irritate the nerve fibers surrounding the disc and lead to complications like spinal stenosis, a compression of the spinal canal and nerve roots in the canal.

In both PRP and stem cell therapy, a patient’s own biologic material is withdrawn, processed in a centrifuge and then reintroduced to the body by injection into the offending spinal disc.

PRP simply involves the withdrawal of blood – akin to having a blood test, Dr. Arora says.
Whole blood contains more than 90 percent red blood cells and only about 1 percent white blood cells. The centrifuge process removes most red cells, which can “aggravate” a patient following treatment, and leaves a platelet-rich fluid. “White blood cells remain in the concentrate because they are difficult to remove, number one, and because they have antibacterial properties that lower risk of infection and can aid healing,” Dr. Arora says.

In stem-cell therapy, cells obtained from bone marrow or adipose (fat) tissue are centrifuged to identify and obtain the specific, “primitive” cells needed to encourage and stimulate regeneration of the collagen when injected into a damaged spinal disc.

Dr. Arora agrees that more research is needed to perfect these techniques and improve outcomes. For example, some experts are warning against PRP to treat orthopedic injuries in children and adolescent athletes, due to insufficient study of the therapy’s safety and impact in the young. Others point to needed improvements and standardization of centrifuging processes.

However, Dr. Arora remains excited about the future of these new approaches.
“All of us carry within ourselves the molecular material for restoring and returning damaged or aged tissue to health,” he says. “That’s what makes these biologic therapies so promising. They are utilizing our own resources to treat injury and disease successfully.”

Atlantic Spine Center is a nationally recognized leader for endoscopic spine surgery with several locations in NJ and NYC.,

Jason Arora, DO, is a board-certified physician who is fellowship-trained in interventional spine and pain management at Atlantic Spine Center.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology news :

1. Horizon Discovery Presents an Educational Webinar on CRISPR-Cas9 Genome Engineering in Primary T cells
2. Asymmetrex Proposes “Stemgene Therapy” to Emphasize the Importance of Tissue Stem Cells for Successful Gene Therapy
3. Venture Fund with Key Focus on Alzheimers Announces Investment in M3 Biotechnology and Its Drug Aimed at Regrowing Brain Cells
4. Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers
5. Identifying the source of stem cells
6. Scientists sniff out unexpected role for stem cells in the brain
7. Researchers develop new cells meant to form blood vessels, treat peripheral artery disease
8. Cancer therapy: Driving cancer cells to suicide
9. Cells from placentas safe for patients with multiple sclerosis
10. Skin cells can be engineered into pulmonary valves for pediatric patients
11. Hey1 and Hey2 ensure inner ear hair cells are made at the right time, in the right place
Post Your Comments:
(Date:11/3/2018)... ... November 01, 2018 , ... Dr. Bryan Choi, a postdoctoral fellow in ... Harvard Medical School, has been awarded the 2018 xCELLigence Immunotherapy Research Grant by ... Medicine, is a promising form of treatment designed to harness a patient’s own immune ...
(Date:11/3/2018)... ... November 01, 2018 , ... Endodontics ... and pathology of the human dental pulp and periradicular tissues. Recent technological advancements ... teeth, but, over the last decade, non-destructive, high-resolution micro-CT 3D imaging has become ...
(Date:10/31/2018)... ... , ... ODSC West 2018, the latest in the largest conference series for ... event offers more than 200 training sessions and workshops led by the best industry ... state of the art. , ODSC West 2018 will yet again be the ...
Breaking Biology News(10 mins):
(Date:10/31/2018)... ... October 30, 2018 , ... Today, the National Corn Growers ... of this global competition is to find new and innovative uses of field corn. ... farmers produced 14.6 billion bushels of corn and are on pace to produce the ...
(Date:10/25/2018)... ... 2018 , ... To prepare for radiological and nuclear emergencies, the U.S. Department ... LLC to repurpose its commercial Silverlon ® technology for radiation injuries of ... has been awarded a three-year, $8.4 million contract with the Biomedical Advanced Research and ...
(Date:10/24/2018)... SAN FRANCISCO (PRWEB) , ... October 22, 2018 ... ... addition of Dr. Philip Bourne, PhD, Director of the Data Science Institute, Stephenson ... UVA, to its Scientific Advisory Board. Joining the board of leading scientists and ...
(Date:10/24/2018)... ... October 23, 2018 , ... Molecular ... new, exciting brand for its recently created biologics solutions business unit. The business ... portfolio of products, and henceforth will be known as ForteBio. It is accompanied ...
Breaking Biology Technology: